Loading...
Loading...
- 3M Co MMM reported Q1 sales of $8.03 billion, down 9.0% Y/Y, beating the consensus of $7.49 billion.
- Organic sales fell 4.9% Y/Y, which included headwinds of 1.3% from divestitures and 2.8% from foreign currency translations.
- Adjusted sales were down 9.7% Y/Y on an organic sales decline of 5.6% Y/Y, with a 3.4% headwind from the lower disposable respirator demand and the 2022 exit from Russia.
- Adjusted EPS of $1.97 beat the consensus of $1.58.
- Adjusted operating margin fell by 410 bps to 17.9%.
- Adjusted free cash flow grew 24% Y/Y to $0.9 billion.
- Restructuring Action: 3M announced restructuring actions which will impact around 6,000 positions globally, along with a reduction of 2,500 global manufacturing roles announced in January 2023.
- The company expects total pre-tax charges of $700 million to $900 million (including previously announced actions in January 2023), with around half of these charges projected in 2023 ($175 million-$250 million in Q2 2023).
- 3M expects annual pre-tax savings of $700 million-$900 million post-completion of restructuring actions
- FY23 Outlook Reaffirmed: 3M continues to expect -6% to -2% adjusted total sales growth and -3% to flat adjusted organic sales growth.
- The company still expects adjusted EPS of $8.50 - $9.00 vs the consensus of $8.60.
- Price Action: MMM shares are trading higher by 1.37% at $106.50 in the premarket on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in